Urinary retention
≈ 7 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Urinary retention is an inability to completely empty the bladder. Onset can be sudden or gradual. When it is of sudden onset, symptoms include an inability to urinate and lower abdominal pain, while symptoms accompanying gradual onset may include loss of bladder control, mild lower abdominal pain, and a weak urine stream. About 7 per 100,000 of the general population are affected annually, and those with long-term urinary retention are at risk of urinary tract infections.
Causes include blockage of the urethra, nerve problems, certain medications, and weak bladder muscles. Blockage can be caused by benign prostatic hyperplasia (BPH), urethral strictures, bladder stones, a cystocele, constipation, or tumors. Nerve problems can occur from diabetes, trauma, spinal cord problems, stroke, or heavy metal poisoning. Medications that can cause problems include anticholinergics, antihistamines, tricyclic antidepressants, cyclobenzaprine, diazepam, nonsteroidal anti-inflammatory drugs (NSAID), stimulants, and opioids.
Diagnosis is typically based on measuring the amount of urine in the bladder after urinating. Treatment is typically with a catheter either through the urethra or lower abdomen. Other treatments may include medication to decrease the size of the prostate, urethral dilatation, a urethral stent, or surgery.…
Urinary retention is an inability to completely empty the bladder. Onset can be sudden or gradual. When it is of sudden onset, symptoms include an inability to urinate and lower abdominal pain, while symptoms accompanying gradual onset may include loss of bladder control, mild lower abdominal pain, and a weak urine stream. About 7 per 100,000 of the general population are affected annually, and those with long-term urinary retention are at risk of urinary tract infections.
Causes include blockage of the urethra, nerve problems, certain medications, and weak bladder muscles. Blockage can be caused by benign prostatic hyperplasia (BPH), urethral strictures, bladder stones, a cystocele, constipation, or tumors. Nerve problems can occur from diabetes, trauma, spinal cord problems, stroke, or heavy metal poisoning. Medications that can cause problems include anticholinergics, antihistamines, tricyclic antidepressants, cyclobenzaprine, diazepam, nonsteroidal anti-inflammatory drugs (NSAID), stimulants, and opioids.
Diagnosis is typically based on measuring the amount of urine in the bladder after urinating. Treatment is typically with a catheter either through the urethra or lower abdomen. Other treatments may include medication to decrease the size of the prostate, urethral dilatation, a urethral stent, or surgery. Males are far more often affected than females, at a ratio of 13:1, in particular because of their possession of a prostate gland but also because their urethra is more susceptible to strictures, as it is far longer than the female one.
In men, acute urinary retention is usually secondary to BPH. In males over the age of 40 about 6 per 1,000 are affected a year; among males over 80 this proportion increases to 30%.
Bladder
Infection Detrusor sphincter dyssynergia Neurogenic bladder (commonly spinal cord damage, pelvic splanchnic nerve damage, cauda equina syndrome, pontine micturition or storage center lesions, demyelinating diseases, multiple system atrophy, genital herpes, or meningitis-retention syndrome) Iatrogenic (caused by medical treatment/procedure) scarring of the bladder neck (commonly from removal of indwelling catheters or cystoscopy operations) Damage to the bladder
Prostate
Benign prostatic hyperplasia (BPH) Prostate cancer and other pelvic malignancies Prostatitis
Penile urethra
Congenital urethral valves Phimosis or pinhole meatus Circumcision Obstruction in the urethra, for example a stricture (usually caused either by injury or STD), a metastasis or a precipitated pseudogout crystal in the urine Pseudodyssynergia STD lesions (gonorrhoea causes numerous strictures, leading to a "rosary bead" appearance, whereas chlamydia usually causes a single stricture) Emasculation
Postoperative
Risk factors include Age: Older people may have degeneration of neural pathways involved with bladder function and it can lead to an increased risk of postoperative urinary retention. The risk of postoperative urinary retention increases up to 2.11 fold for people older than 60 years. Medications: Anticholinergics and medications with anticholinergic properties, alpha-adrenergic agonists, opiates, nonsteroidal anti-inflammatories (NSAIDs), calcium-channel blockers and beta-adrenergic agonists, may increase the risk.
Anesthesia: General anesthetics during surgery may cause bladder atony by acting as a smooth muscle relaxant. General anesthetics can directly interfere with autonomic regulation of detrusor tone and predispose people to bladder overdistention and subsequent retention. Spinal anesthesia results in a blockade of the micturition reflex. Spinal anesthesia shows a higher risk of postoperative urinary retention compared to general anesthesia.
Benign prostatic hyperplasia: Men with benign prostatic hyperplasia are at an increased risk of acute urinary retention. Surgery related: Operative times longer than 2 hours may lead to an increased risk of postoperative urinary retention 3-fold. Postoperative pain.
Chronic
Chronic urinary retention that is due to bladder blockage which can either be as a result of muscle damage or neurological damage. If the retention is due to neurological damage, there is a disconnect between the brain to muscle communication, which can make it impossible to completely empty the bladder. If the retention is due to muscle damage, it is likely that the muscles are not able to contract enough to completely empty the bladder. The most common cause of chronic urinary retention is BPH.
Other
Tethered spinal cord syndrome. Psychogenic causes – psychosocial stresses, fear associated with urination, paruresis ("shy bladder syndrome") – in extreme cases, urinary retention can result. noradrenergic drugs, that includes tricyclic antidepressants, as well as duloxetine, reboxetine, atomoxetine, venlafaxine, and stimulants, such as methylphenidate, amphetamine and MDMA. Use of NSAIDs, or drugs with anticholinergic properties. Stones or metastases, which can theoretically appear anywhere along the urinary tract, but vary in frequency depending on anatomy. Muscarinic antagonists such as atropine and scopolamine. Malfunctioning artificial urinary sphincter.
Medication
α1-receptor antagonists and 5α-reductase inhibitors
Urinary retention, including drug-induced cases, may be an early sign of benign prostatic hyperplasia (BPH). Treatment typically includes α1-receptor antagonists such as tamsulosin, which relaxes smooth muscle in the bladder neck, and 5α-reductase inhibitors like finasteride and dutasteride, which reduce prostate enlargement. Clinical trials have demonstrated that combining these medications improves urinary symptoms and lowers the likelihood of retention recurrence.
Striated muscle relaxants
Baclofen, a gamma-aminobutyric acid (GABA) agonist, acts on GABAergic interneurons in the sacral intermediolateral cell column, facilitating the relaxation of the striated urinary sphincter during voiding. Some evidence suggests it may be beneficial for women with bladder outlet obstruction and pediatric patients.
Opioid antagonists
Naloxone, has been tested for urinary retention following epidural or intrathecal anesthesia. While effective, it also reverses analgesia, making it unsuitable for postoperative cases. Nalbuphine, a mixed agonist/antagonist opioid modulator, has shown promise in a reported case of postoperative urinary retention, preserving analgesia while relieving retention. Further studies are needed to confirm its efficacy.
Surgery
The chronic form of urinary retention may require some type of surgical procedure. While both procedures are relatively safe, complications can occur. In most patients with benign prostate hyperplasia (BPH), a procedure known as transurethral resection of the prostate (TURP) may be performed to relieve bladder obstruction. Surgical complications from TURP include a bladder infection, bleeding from the prostate, scar formation, inability to hold urine, and inability to have an erection. The majority of these complications are short lived, and most individuals recover fully within 6–12 months.
Sitting voiding position
A meta-analysis on the influence of voiding position on urodynamics in males with lower urinary tract symptoms showed that in the sitting position, the residual urine in the bladder was significantly reduced, the maximum urinary flow was increased, and the voiding time was decreased. For healthy males, no influence was found on these parameters, meaning that they can urinate in either position.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1366282950 under CC BY-SA 4.0; modifications have been made.